Effect of Sustained-Release Cetylpyridinium Chloride Varnish on Streptococcus Mutans and Lactobacillus in Orthodontic Patients

Sponsor
Hadassah Medical Organization (Other)
Overall Status
Unknown status
CT.gov ID
NCT00416286
Collaborator
(none)
30

Study Details

Study Description

Brief Summary

The purpose of the study is to was to evaluate the anti bacterial efficacy of sustain-release Cetylpyridinium chloride varnish on orthodontic patients.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Defined Population
    Time Perspective:
    Prospective
    Official Title:
    Phase 1: To Evaluate the Antibacterial Efficacy of Sustained Release Cetylpyridinium Chloride Varnish in Orthodontic Patients

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      12 Years to 18 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Exclusion Criteria:
      • Children under 12y old

      Contacts and Locations

      Locations

      No locations specified.

      Sponsors and Collaborators

      • Hadassah Medical Organization

      Investigators

      • Principal Investigator: Doron Harari, DMD, Orthodontic department, Dental school Hadassah Ein Kerem

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00416286
      Other Study ID Numbers:
      • 26-23.12.05-HMO-CTIL
      • 26-23.12.05
      • code: 1371
      First Posted:
      Dec 27, 2006
      Last Update Posted:
      Dec 27, 2006
      Last Verified:
      Dec 1, 2006

      Study Results

      No Results Posted as of Dec 27, 2006